Abstract:Recent studies suggest that urotensin II (UII) and transforming growth factor-β1 (TGF-β1) both have critical roles in vascular remodeling. UII is a recently discovered vasoconstrictive peptide that is involved in the pathogenesis of atherosclerosis, restenosis and hypertension. TGF-β1 is an important factor that has a pivotal role in vascular fibrosis. This study aimed to explore whether TGF-β1 is involved in UII-induced collagen synthesis in rat aortic vascular smooth muscle cells (VSMCs) and examined the effects and mechanisms of UII on collagen synthesis and secretion in VSMCs. VSMCs were prepared by the explant culture method. TGF-β1 and collagen I secretions from the cells were determined by enzyme-linked immunosorbent assay (ELISA). The mRNA and protein expressions of TGF-β1, collagen I, Smad2 and Smad3 were determined using Real-time RT-PCR and Western blotting. UII dose-dependently promoted TGF-β1 protein expression and secretion from VSMCs, with maximal effect at 10− 8 mol/l at 24 h for protein expression and 10− 7 mol/l at 24 h for protein secretion (both P < 0.01). Moreover, UII dose-dependently promoted Smad2 and Smad3 mRNA expression in VSMCs, with maximal effect at 10− 8 mol/l for 12 h (both P < 0.01). The effects of UII were significantly inhibited by its receptor antagonists urantide (10− 6 mol/l) or SB-710411 (10− 6 mol/l), and by the mitogen-activated protein kinase (MAPK/ERK) inhibitor PD98059 (10− 6 mol/l). UII dose-dependently promoted collagen I mRNA expression and protein secretion in VSMCs, with maximal effect at 10− 8 mol/l at 12 h for mRNA expression and 10− 6 mol/l at 24 h for protein secretion (both P < 0.01). Collagen synthesis and secretion from VSMCs induced by UII were inhibited significantly by a TGF-β1-specific neutralizing antibody, SB-431542 (an antagonist of the TGF-β1 type II receptor) and PD98059 (all P < 0.01). This study suggests that UII could induce collagen synthesis and secretion through upregulation of TGF-β1 expression and secretion in VSMCs, and that TGF-β1/Smad2/3 signaling might be one of the important pathways by which UII is involved in vascular fibrosis.

Chemical proteomics reveals ligustilide targets SMAD3, inhibiting collagen synthesis in aortic endothelial cells

Ligustilide attenuates airway remodeling in COPD mice by covalently binding to MH2 domain of Smad3 in pulmonary epithelium, disrupting the Smad3‐SARA interaction

The Protective Effect of Ligustilide in Osteoarthritis: An in Vitro and in Vivo Study

Protocatechualdehyde reduces myocardial fibrosis by directly targeting conformational dynamics of collagen

Salvianolic acid A diminishes LDHA-driven aerobic glycolysis to restrain myofibroblasts activation and cardiac fibrosis via blocking Akt/GSK-3β/HIF-1α axis

Sanglifehrin A mitigates multi-organ fibrosis in vivo by inducing secretion of the collagen chaperone cyclophilin B

Ligustilide covalently binds to Cys129 of HMGCS1 to ameliorate dyslipidemia

Stabilised pathway and its anti-oxygen/glucose deprived activity about ligustilide, as a pharmacodynamic marker for Angelica sinensis (Oliv) Diles or Ligusticum chuanxiong Hort

Phthalide Lactones from Ligusticum Chuanxiong Inhibit Lipopolysaccharide-Induced Tnf-Alpha Production and Tnf-Alpha-Mediated Nf-Kappa B Activation

Systems pharmacology approach uncovers Ligustilide attenuates experimental colitis in mice by inhibiting PPARγ-mediated inflammation pathways

18 Alpha-Glycyrrhetinic Acid Down-Regulates Expression Of Type I And Iii Collagen Via Tgf-B1/Smad Signaling Pathway In Human And Rat Hepatic Stellate Cells

Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1

Urotensin II-induced Collagen Synthesis in Cultured Smooth Muscle Cells from Rat Aortic Media and a Possible Involvement of Transforming Growth Factor-Β1/smad2/3 Signaling Pathway

TGF-β1/Smad3 Signaling Promotes Collagen Synthesis in Pulmonary Artery Smooth Muscle by Down-Regulating Mir-29B.

Effect of Hydrogen Sulfide on Collagen Synthesis in Rat Cardiomyocytes Through Down Regulation of TGF-β1/Smad2/3 Signaling Pathway

Salvianolic Acid A, A Novel Matrix Metalloproteinase-9 Inhibitor, Prevents Cardiac Remodeling In Spontaneously Hypertensive Rats

Oleanolic Acid Derivative Alleviates Cardiac Fibrosis Through Inhibiting PTP1B Activity and Regulating AMPK/TGF-β/Smads Pathway.

Flavones Hydroxylated at 5, 7, 3′ and 4′ Ameliorate Skin Fibrosis Via Inhibiting Activin Receptor-Like Kinase 5 Kinase Activity

Abstract 487: Dihyrosphingosine 1 Phosphate Mediates Collagen Synthesis in Cardiac Fibroblasts Throught Pi3k/akt- Mtor Signalling Pathway

Resveratrol inhibits the expression of typeⅠ and type Ⅲ collagen induced by AngⅡ in cardiac fibroblasts through regulating the TGF-β1/Smad3 signaling pathway

Inhibitory effects of Schisandrin C on collagen behavior in pulmonary fibrosis